Article
IDH mutations in glioma and acute myeloid leukemia.
Trends in molecular medicine - 1 Sept 2010
Dang Lenny, Jin Shengfang, Su Shinsan M
Abstract excerpt
The systematic sequencing of glioblastoma multiforme (GBM) genomes has identified the recurrent mutation of IDH1, a gene encoding NADP(+)-dependent isocitrate dehydrogenase 1 (IDH1) that catalyzes the oxidative decarboxylation of isocitrate yielding alpha-ketoglutarate (alpha-KG). Subsequent studies have confirmed recurrent IDH1 and IDH2 mutations in up to 70% of low-grade glioma and secondary GBM, as well as in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
